This archive contains links to the full-text of all issues of Clin Mol Hepatol.
![]() |
First decision
07 Days
Publication after acceptance
04 Days
*Last 12 months
Viewed By 7189 |
MAFLD: How is it different from NAFLD? |
Viewed By 6637 |
Epidemiology of metabolic dysfunction-associated steatotic liver disease |
Viewed By 5472 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Viewed By 5259 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Viewed By 4735 |
Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease |
Cited By 298 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Cited By 269 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Cited By 181 |
MAFLD: How is it different from NAFLD? |
Cited By 93 |
Non-alcoholic fatty liver disease: Definition and subtypes |
Cited By 88 |
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis |